Page last updated: 2024-09-03

gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate and oligonucleotides

gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate has been researched along with oligonucleotides in 2 studies

Compound Research Comparison

Studies
(gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate)
Trials
(gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate)
Recent Studies (post-2010)
(gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate)
Studies
(oligonucleotides)
Trials
(oligonucleotides)
Recent Studies (post-2010) (oligonucleotides)
6383124323,1282457,331

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Bergan, RC; Dharmakumar, R; Ke, T; Lai, B; Larson, A; Li, D; Lu, ZR; Mascheri, N; Maser, J; Omary, R; Paunesku, T; Szolc-Kowalska, B; Thurn, K; Vogt, S; Woloschak, GE; Wu, A1
Chen, C; Chen, Z; Cheng, X; Dai, J; Guo, Y; He, Y; Huang, G; Huang, T; Lin, X; Ouyang, D; Rozhkova, EA; Ruan, J; Song, S; Wang, Q; Wu, M; Xie, J; Yang, H1

Other Studies

2 other study(ies) available for gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate and oligonucleotides

ArticleYear
Gadolinium-conjugated TiO2-DNA oligonucleotide nanoconjugates show prolonged intracellular retention period and T1-weighted contrast enhancement in magnetic resonance images.
    Nanomedicine : nanotechnology, biology, and medicine, 2008, Volume: 4, Issue:3

    Topics: Cell Line, Tumor; Contrast Media; Dopamine; Gadolinium; Heterocyclic Compounds; Humans; Magnetic Resonance Imaging; Nanostructures; Oligonucleotides; Organometallic Compounds; Polyglutamic Acid; Titanium

2008
Dual-Responsive Turn-On T
    Advanced healthcare materials, 2023, Volume: 12, Issue:28

    Topics: Cell Line, Tumor; DNA, Catalytic; Heterocyclic Compounds; Nanoparticles; Neoplasms; Oligonucleotides; Oligonucleotides, Antisense; Organometallic Compounds; Phototherapy

2023